These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study. Enoch J; Ghulakhszian A; Crabb DP; Dinah C; Taylor DJ BMJ Open; 2021 Apr; 11(4):e049495. PubMed ID: 33895721 [TBL] [Abstract][Full Text] [Related]
23. Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration. Akyol E; Lotery A Biologics; 2020; 14():83-94. PubMed ID: 32982165 [TBL] [Abstract][Full Text] [Related]
24. Emerging Therapies in Nonexudative Age-Related Macular Degeneration in 2020. Samanta A; Aziz AA; Jhingan M; Singh SR; Khanani AM; Chhablani J Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):408-416. PubMed ID: 33512911 [TBL] [Abstract][Full Text] [Related]
25. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Manjunath V; Goren J; Fujimoto JG; Duker JS Am J Ophthalmol; 2011 Oct; 152(4):663-8. PubMed ID: 21708378 [TBL] [Abstract][Full Text] [Related]
26. Advancements in the treatment of age-related macular degeneration: a comprehensive review. Papaioannou C Postgrad Med J; 2024 Jun; 100(1185):445-450. PubMed ID: 38330506 [TBL] [Abstract][Full Text] [Related]
27. Outer retinal tubulation formation and clinical course of advanced age-related macular degeneration. Arrigo A; Aragona E; Battaglia O; Saladino A; Amato A; Borghesan F; Pina A; Calcagno F; Hassan Farah R; Bandello F; Battaglia Parodi M Sci Rep; 2021 Jul; 11(1):14735. PubMed ID: 34282240 [TBL] [Abstract][Full Text] [Related]
28. Emixustat and Lampalizumab: Potential Therapeutic Options for Geographic Atrophy. Jack LS; Sadiq MA; Do DV; Nguyen QD Dev Ophthalmol; 2016; 55():302-9. PubMed ID: 26501510 [TBL] [Abstract][Full Text] [Related]
29. A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration. Halawa OA; Lin JB; Miller JW; Vavvas DG J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208067 [TBL] [Abstract][Full Text] [Related]
30. Epimacular brachytherapy for wet AMD: current perspectives. Casaroli-Marano RP; Alforja S; Giralt J; Farah ME Clin Ophthalmol; 2014; 8():1661-70. PubMed ID: 25210436 [TBL] [Abstract][Full Text] [Related]
31. Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration. Schmid MK; Thiel MA; Lienhard K; Schlingemann RO; Faes L; Bachmann LM Eye (Lond); 2019 Oct; 33(10):1584-1589. PubMed ID: 31043690 [TBL] [Abstract][Full Text] [Related]
32. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option. Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372 [TBL] [Abstract][Full Text] [Related]
33. Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema. Shaw LT; Mackin A; Shah R; Jain S; Jain P; Nayak R; Hariprasad SM Expert Opin Investig Drugs; 2020 Jun; 29(6):547-554. PubMed ID: 32349559 [TBL] [Abstract][Full Text] [Related]
35. Age-Related Macular Degeneration: What Do We Know So Far? Ma HH; Liutkevičienė R Acta Med Litu; 2021; 28(1):36-47. PubMed ID: 34393627 [TBL] [Abstract][Full Text] [Related]
36. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517 [TBL] [Abstract][Full Text] [Related]
37. IL-33trap-mediated IL-33 neutralization does not exacerbate choroidal neovascularization, but fails to protect against retinal degeneration in a dry age-related macular degeneration model. Van Hove I; Van Bergen T; Etienne I; Holgado A; Afonina IS; Beyaert R; Feyen JH; Hu TT Exp Eye Res; 2021 Jun; 207():108608. PubMed ID: 33930400 [TBL] [Abstract][Full Text] [Related]
38. Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists. Vakharia P; Eichenbaum D Curr Opin Ophthalmol; 2024 May; 35(3):165-169. PubMed ID: 38421937 [TBL] [Abstract][Full Text] [Related]